
Solpin 750mg Tablet ER
Marketer
Drukst Biotech Private Limited
Salt Composition
Divalproex (750mg)
Overview Solpin 750mg Tablet ER
Epileptic seizures and migraine prophylaxis are key indications for the extended-release Solpin 750mg tablet. It's also sometimes prescribed for bipolar disorder management. Dosage and frequency are determined individually by your physician to optimize symptom control, and can be administered with or without food, consistently at the same time daily for maximum efficacy. Therapeutic effects typically manifest within a couple of weeks. Consistent use, as directed, is crucial; discontinuation or missed doses risk seizure recurrence and condition exacerbation; abrupt cessation is contraindicated. Common, usually mild, side effects encompass headache, blurred vision, nausea, vomiting, vertigo, fatigue, ataxia, easy bruising, and hypothermia. Persistent or troublesome side effects warrant medical consultation, while rash or redness necessitates immediate notification. Prolonged use can potentially reduce bone density (osteoporosis), elevating fracture risk. Suicidal ideation or behavior is a rare but serious potential adverse effect, requiring prompt medical attention if experienced. Prior heart disease, renal or hepatic impairment, urinary retention, depression, or suicidal tendencies must be disclosed before initiating therapy. Drug interactions are possible; inform your doctor of all concurrent medications to ensure safety. Pregnant individuals should consult their physician before initiating or altering Solpin 750mg usage. Alcohol consumption should be avoided due to the increased risk of side effects and seizures. Regular blood tests may be required for dose monitoring, both pre- and post-treatment commencement.
Primary Ingredients of Solpin 750mg Tablet ER
No text was provided to rewrite. Please provide the text you wish to have rephrased.
Uses of Solpin 750mg Tablet ER
Managing epileptic seizures and bipolar disorder; migraine prophylaxis.
Major Benefits of Solpin 750mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Solpin 750mg Extended-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Solpin 750mg Tablet ER:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Solpin 750mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Solpin 750mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Solpin 750mg Tablet ER works:
Epileptic seizures are managed by Solpin 750mg Extended-Release tablets, an anticonvulsant that reduces heightened, irregular neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Solpin 750mg extended-release tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Solpin 750mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Solpin 750mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Solpin 750mg tablets can induce adverse reactions that might impair driving capabilities.
KidneySAFE IF PRESCRIBED
Extended-release Solpin 750mg tablets pose no safety concerns for patients with renal impairment, and no dosage modification is necessary.
LiverUNSAFE
Extended-release Solpin 750mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Solpin 750mg Tablet ER :
Should you forget a Solpin 750mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Solpin 750mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Anticonvulsant sodium channel blockers |
